Myriad Genetics

NASDAQ (MYGN) US$ 7,80 14/10 17:00 -0,04 -0,51%

24hGold TrendPower©: -50

Cours préc.

Ouverture

7,84

7,83

Bas

Haut

7,62

8,07

Volume

Var. YTD

957 720

-43,11%

Shares Oustanding

Mkt Cap Oustanding

68 090 000

531 102 000

Année b/h

52 sem. b/h

3,76 - 15,47

7,62 - 8,07

var. 1 mois

var. 52 sem.

7,73%

-68,92%

Myriad Genetics est une société basée aux Etats-Unis D'Amerique.

Myriad Genetics est cotée aux Etats-Unis D'Amerique. Sa capitalisation boursière aujourd'hui est 531,1 millions US$ (459,0 millions €).

La valeur de son action a atteint son plus haut niveau récent le 17 novembre 2000 à 94,06 US$, et son plus bas niveau récent le 14 octobre 2025 à 7,80 US$.

Myriad Genetics possède 68 090 000 actions en circulation.

Communiqués de Presse

18/08/2017	Increased Confidence Earns Myriad Genetics An Upgrade
18/08/2017	Myriad Genetics' EndoPredict Gets Positive Coverage Decision
17/08/2017	EndoPredict® Receives Positive Coverage Decisions From Medicare and Anthem
16/08/2017	See what the IHS Markit Score report has to say about Myriad Genetics Inc.
14/08/2017	Myriad Genetics (MYGN) Grows on Higher Cancer Test Volumes
10/08/2017	CVS Health Grows on Specialty Pharmacy amid Retail Woes
10/08/2017	Chimerix (CMRX) Q2 Loss Narrower than Expected, Revenues Down
10/08/2017	Haemonetics Banks on Solid Plasma & Haemonetics Management
10/08/2017	Bio-Techne (TECH) Beats Earnings, Revenue Estimates in Q4
10/08/2017	IHS Markit Score Update: Drop in demand for ETFs holding Myriad Genetics Inc is a negative sign for its shares
10/08/2017	Myriad Genetics Inc (MYGN) Files 10-K for the Fiscal Year Ended on June 30, 2017
09/08/2017	Myriad Genetics (MYGN) Beats on Q4 Earnings & Revenues
09/08/2017	Myriad beats Street 4Q forecasts
08/08/2017	Myriad Genetics Reports Fiscal Fourth-Quarter 2017 and Fiscal Full-Year 2017 Financial Results
08/08/2017	Investor Network: Myriad Genetics, Inc. to Host Earnings Call
27/01/2016	Will Myriad Genetics Q2 Earnings (MYGN) Surprise Investors?
31/12/2015	Myriad Genetics Trades above Its 100-Day Moving Average
29/12/2015	10 Biotechs Short Sellers Are Betting Against
22/12/2015	Myriad Genetics: Test Expansion Strong, Currency Woes Linger
08/12/2015	Top Analyst Upgrades and Downgrades: Amazon, Blackstone, FireEye, Myriad Genetics, Visa, CBOE, Hershey, Vail and Many More